Resolution and Prevention of Feline Immunodeficiency Virus-Induced Neurological Deficits by Treatment with the Protease Inhibitor TL-3

Journal of Virology

Volumn 78, Issue 9, 2004, Pages 4525-4532

  Huitron Resendiz, Salvador ^a   De Rozières, Sohela ^a   Sanchez Alavez, Manuel ^a   Bühler, Bernd ^a   Lin, Ying Chuan ^a   Lerner, Danica L ^a   Henriksen, Nicholas W ^a   Burudi, Mboya ^a   Fox, Howard S ^a   Torbett, Bruce E ^a   Henriksen, Steven ^a   Elder, John H ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; PROTEINASE INHIBITOR; TL 3; UNCLASSIFIED DRUG; VIRUS RNA;

ANIMAL EXPERIMENT; ARTICLE; CAT; CENTRAL NERVOUS SYSTEM DISEASE; CENTRAL NERVOUS SYSTEM FUNCTION; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; EVOKED BRAIN STEM AUDITORY RESPONSE; FELINE IMMUNODEFICIENCY VIRUS; IMMUNE STATUS; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; SEROCONVERSION; VIROLOGY; VIRUS INFECTION; VIRUS LOAD;

ANIMALS; BRAIN STEM; CAT DISEASES; CATS; CENTRAL NERVOUS SYSTEM DISEASES; EVOKED POTENTIALS, AUDITORY, BRAIN STEM; FELINE ACQUIRED IMMUNODEFICIENCY SYNDROME; IMMUNODEFICIENCY VIRUS, FELINE; PROTEASE INHIBITORS; TREATMENT OUTCOME;

EID: 16544368098     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.78.9.4525-4532.2004     Document Type: Article

References (31)

1. Buhler, B., Y. C. Lin, G. Morris, A. J. Olson, C. H. Wong, D. D. Richman, J. H. Elder, and B. E. Torbett. 2001. Viral evolution in response to the broad-based retroviral protease inhibitor TL-3. J. Virol. 75:9502-9508.
2. Collier, A. C., R. W. Coombs, D. A. Schoenfeld, R. L. Bassett, J. Timpone, A. Baruch, M. Jones, K. Facey, C. Whitacre, V. J. McAuliffe, H. M. Friedman, T. C. Merigan, R. C. Reichman, C. Hooper, and L. Corey. 1996. Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. N. Engl. J. Med. 334:1011-1017.
3. Dow, S. W., M. L. Poss, and E. A. Hoover. 1990. Feline immunodeficiency virus: a neurotropic lentivirus. J. Acquir. Immune Defic. Syndr. 3:658-668.
4. Egberink, H., J. Ederveen, M. Koolen, H. Lutz, and M. C. Horzinek. 1988. Infections with feline T-lymphotropic lentivirus. Tijdschr. Diergeneeskd. 113:937-943.
5. Elder, J. H., M. Schnolzer, C. S. Hasselkus-Light, M. Henson, D. A. Lerner, T. R. Phillips, P. C. Wagaman, and S. B. Kent. 1993. Identification of proteolytic processing sites within the Gag and Pol polyproteins of feline immunodeficiency virus. J. Virol. 67:1869-1876.
6. Gulick, R. M., J. W. Mellors, D. Havlir, J. J. Eron, C. Gonzalez, D. McMahon, D. D. Richman, F. T. Valentine, L. Jonas, A. Meibohm, E. A. Emini, and J. A. Chodakewitz. 1997. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. N. Engl. J. Med. 337:734-739.
7. Hurtrel, M., J. P. Ganiere, J. F. Guelfi, L. Chakrabarti, M. A. Maire, F. Gray, L. Montagnier, and B. Hurtrel. 1992. Comparison of early and late feline immunodeficiency virus encephalopathies. AIDS 6:399-406.
8. Johnson, D. A., J. W. Gautsch, R. Sportsman, and J. H. Elder. 1984. Improved technique utilizing non-fat dry milk for analysis of protein and nucleic acids transferred to nitrocellulose. Gene Anal. Tech. 1:3-8.
9. Kirk, O., T. L. Katzenstein, J. Gerstoft, L. Mathiesen, H. Nielsen, C. Pedersen, and J. D. Lundgren. 1999. Combination therapy containing ritonavir plus saquinavir has superior short-term antiretroviral efficacy: a randomized trial. AIDS 13:F9-F16.
10. Klein, D., C. M. Leutenegger, C. Bahula, P. Gold, R. Hofmann-Lehmann, B. Salmons, H. Lutz, and W. H. Gunzburg. 2001. Influence of preassay and sequence variations on viral load determination by a multiplex real-time reverse transcriptase-polymerase chain reaction for feline immunodeficiency virus. J. Acquir. Immune Defic. Syndr. 26:8-20.
11. Kubicki, S., K. Henkes, K. Terstegge, and B. Ruf. 1988. HIV and the nervous system. Fischer, New York, N.Y.
12. Lee, T., G. S. Laco, B. E. Torbett, H. S. Fox, D. L. Lerner, J. H. Elder, and C. H. Wong. 1998. Analysis of the S3 and S3′ subsite specificities of feline immunodeficiency virus (FIV) protease: development of a broad-based protease inhibitor efficacious against FIV, SIV, and HIV in vitro and ex vivo. Proc. Natl. Acad. Sci. USA 95:939-944.
13. Lee, T., V.-D. Le, Y.-C. Lin, A. L. Wong, J. H. Elder, and C.-H. Wong. 1999. Development of a new type of protease inhibitors with small P3 residue efficacious against FIV and HIV variants. J. Am. Chem. Soc. 121:1145-1155.
14. Lerner, D. L., P. C. Wagaman, T. R. Phillips, O. Prospero-Garcia, S. J. Henriksen, H. S. Fox, F. E. Bloom, and J. H. Elder. 1995. Increased mutation frequency of feline immunodeficiency virus lacking functional deoxyuridine-triphosphatase. Proc. Natl. Acad. Sci. USA 92:7480-7484.
15. Nazarenko, I., R. Pires, B. Lowe, M. Obaidy, and A. Rashtchian. 2002. Effect of primary and secondary structure of oligodeoxyribonucleotides on the fluorescent properties of conjugated dyes. Nucleic Acids Res. 30:2089-2095.
16. Norman, S. E., A. D. Chediak, M. Kiel, and M. A. Cohn. 1990. Sleep disturbances in HIV-infected homosexual men. AIDS 4:775-781.
17. Palella, F. J., Jr., K. M. Delaney, A. C. Moorman, M. O. Loveless, J. Fuhrer, G. A. Satten, D. J. Aschman, and S. D. Holmberg. 1998. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N. Engl. J. Med. 338:853-860.
18. Pedersen, N. C., E. H. Ho, M. L. Brown, and J. K. Yamamoto. 1987. Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome. Science 235:790-793.
19. Phillips, T. R., O. Prospero-Garcia, D. L. Puaoi, D. L. Lerner, H. S. Fox, R. A. Olmsted, F. E. Bloom, S. J. Henriksen, and J. H. Elder. 1994. Neurological abnormalities associated with feline immunodeficiency virus infection. J. Gen. Virol. 75(Pt. 5):979-987.
20. Phillips, T. R., O. Prospero-Garcia, D. W. Wheeler, P. C. Wagaman, D. L. Lerner, H. S. Fox, L. R. Whalen, F. E. Bloom, J. H. Elder, and S. J. Henriksen. 1996. Neurologic dysfunctions caused by a molecular clone of feline immunodeficiency virus, FIV-PPR. J. Neurovirol. 2:388-396.
21. Podell, M., M. Oglesbee, L. Mathes, S. Krakowka, R. Olmstead, and L. Lafrado. 1993. AIDS-associated encephalopathy with experimental feline immunodeficiency virus infection. J. Acquir. Immune Defic. Syndr. 6:758-771.
22. Prospero-Garcia, O., N. Herold, T. R. Phillips, J. H. Elder, F. E. Bloom, and S. J. Henriksen. 1994. Sleep patterns are disturbed in cats infected with feline immunodeficiency virus. Proc. Natl. Acad. Sci. USA 91:12947-12951.
23. Prospero-Garcia, O., N. Herold, A. K. Waters, T. R. Phillips, J. H. Elder, and S. J. Henriksen. 1994. Intraventricular administration of a FIV-envelope protein induces sleep architecture changes in rats. Brain Res. 659:254-258.
24. Prospero-Garcia, O., S. Huitron-Resendiz, S. C. Casalman, M. Sanchez-Alavez, O. Diaz-Ruiz, L. Navarro, D. L. Lerner, T. R. Phillips, J. H. Elder, and S. J. Henriksen. 1999. Feline immunodeficiency virus envelope protein (FIVgp120) causes electrophysiological alterations in rats. Brain Res. 836: 203-209.
25. Schnolzer, M., H. R. Rackwitz, A. Gustchina, G. S. Laco, A. Wlodawer, J. H. Elder, and S. B. Kent. 1996. Comparative properties of feline immunodeficiency virus (FIV) and human immunodeficiency virus type 1 (HIV-1) proteinases prepared by total chemical synthesis. Virology 224:268-275.
26. Shetty, B. V., M. B. Kosa, D. A. Khalil, and S. Webber. 1996. Preclinical pharmacokinetics and distribution to tissue of AG1343, an inhibitor of human immunodeficiency virus type 1 protease. Antimicrob. Agents Chemother. 40:110-114.
27. Tachibana, H., K. Kawabata, M. Takeda, and M. Sugita. 1993. Multimodal evoked potentials in Binswanger's disease and Alzheimer's disease. Int. J. Neurosci. 69:197-206.
28. Tachibana, H., M. Takeda, and M. Sugita. 1989. Brainstem auditory evoked potentials in patients with multi-infarct dementia and dementia of the Alzheimer type. Int. J. Neurosci. 48:325-331.
29. Tachibana, H., M. Takeda, and M. Sugita. 1989. Short-latency somatosensory and brainstem auditory evoked potentials in patients with Parkinson's disease. Int. J. Neurosci. 44:321-326.
30. Yamamoto, J. K., H. Hansen, E. Ho, T. Morishita, T. Okuda, T. Sawa, R. Nakamura, and N. Pedersen. 1989. Epidemiologic and clinical aspects of feline immunodeficiency virus infection in cats from the continental United States and Canada and possible mode of transmission. J. Am. Vet. Med. Assoc. 194:213-220.
31. Yuan, J. H., J. C. Stolzenbach, C. M. Salamon, S. S. Snook, and G. L. Schoenhard. 1997. Improvement of bioavailability of the HIV protease inhibitor SC-52151 in the beagle dog by coadministration of the CYP3A4 inhibitor, ketoconazole. Xenobiotica 27:489-497.